A phase 2, single-arm trial evaluating 131I-PSMA-1095 targeted radioligand therapy for metastatic castrationresistant prostate cancer.

Details

Language :

English

ISSN :

01433636

Volume :

45

Issue :

8

Database :

Complementary Index

Journal :

Nuclear Medicine Communications

Publication Type :

Academic Journal

Accession number :

178981256

Full Text :

https://doi.org/10.1097/MNM.0000000000001858